HIV integrase inhibitors

US7135467B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Michael A. Walker · Durham, US
• Hatice Belgin Gulgeze · Middletown, US
• Narasimhulu B. Naidu · Durham, US
• Margaret E. Sorenson · Swedesburg, US
• Yasutsugu Ueda · Clinton, US
• John D. Matiskella · Wallingford, US

Key dates

• Filing date: Jan 12, 2004
• Grant date: Nov 14, 2006
• Expiry date: Jan 6, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds useful for treating HIV are disclosed having the general formulawherein R1, R2, and B are as defined in the specification. Compositions containing the compounds and methods for using the compounds to inhibit HIV are also disclosed.